On Monday, Copa Holdings, S.A. (NYSE:CPA)’s shares showed no change to $45.00.
Copa Holdings, S.A. (CPA), released preliminary passenger traffic statistics for August 2015:
For the month of August 2015, Copa Holdings’ system-wide passenger traffic (RPM) reduced 3.5% year over year, while capacity raised 1.1%. As a result, system load factor for August 2015 was 74.4%, a 3.5 percentage point decrease when contrast to August 2014.
Copa Holdings, S.A. provides airline passenger and cargo services in Latin America. It offers services within Colombia; and international flights from various cities in Colombia to Panama, Venezuela, Ecuador, México, Cuba, Guatemala, and Costa Rica. The company offers about 355 daily planned flights among 69 destinations in 30 countries in North, Central, and South America, in addition to the Caribbean from its Panama City hub.
Rovi Corporation (NASDAQ:ROVI)’s shares dropped -4.60% to $11.41.
Rovi Corporation (ROVI) stated financial results for the second quarter ended June 30, 2015.
The Company stated second quarter revenue of $127.8 million, a decrease of 7% contrast to $137.1 million in the second quarter of 2014. Revenues were lower than in the comparable period of the preceding year, which benefited from higher Consumer Electronics revenues, in part due to one-time revenues from Samsung. Second quarter 2015 Income from ongoing operations, net of tax, was $3.3 million, contrast to $2.7 million Loss from ongoing operations, net of tax, for the second quarter of 2014. Second quarter Diluted income per share from ongoing operations was $0.04, contrast to $0.03 Diluted loss per share from ongoing operations in the second quarter of 2014. After taking into consideration suspended operations, the Company stated second quarter Net income of $3.3 million, contrast to a Net loss of $2.6 million for the same quarter of 2014. Second quarter Diluted income per share was $0.04, contrast to $0.03 Diluted loss per share in the second quarter of 2014.
On a Non-GAAP basis, second quarter Non-GAAP Net Income was $32.7 million, contrast to $39.5 million in the second quarter of 2014, and second quarter Non-GAAP Diluted Income Per Share was $0.38, contrast to $0.43 in the second quarter of 2014.
Rovi Corporation provides integrated solutions for the discovery and personalization of digital entertainment to service providers and consumer electronics (CE) industry worldwide. The company offers interactive program guides (IPGs), an interactive listing of television or video program information that enables viewers to navigate through, sort, select, and plan video programming for viewing and recording. It markets IPGs to service providers under i-Guide and Passport brands; and CE industry under the G-GUIDE and HTML Guide brands.
At the end of Monday’s trade, Intersil Corp (NASDAQ:ISIL)‘s shares surged 1.33% to $10.66.
Intersil Corporation (ISIL), a leading provider of innovative power administration and precision analog solutions, recently declared financial results for the second quarter of 2015. Revenue of $132.4 million was down 1.3% sequentially. Strong gross margin and lower operating expenses resulted in solid operating margin for the eighth successive quarter. The company stated GAAP earnings per share of $0.28 and non-GAAP earnings per share of $0.16.
Company Highlights
- Gross margin performance was strong at 59.3% on a GAAP basis and 59.6% on a non-GAAP basis.
- The company again stated solid profitability, with GAAP operating margin of 12.2% and non-GAAP operating margin of 20.3%.
- Cash and cash equivalents raised to $225 million.
- New products introduced during the quarter represent industry firsts for power administration in tablets and ultrabooks, wearables and industrial applications.
Intersil Corporation designs and develops power administration and precision analog integrated circuits (ICs) for industrial and infrastructure, consumer, and computing markets. The company offers various power IC solutions for battery administration, processor power administration, and display power administration, counting power regulators, converters, and controllers, in addition to integrated power modules.
Intrexon Corp (NYSE:XON), ended its Monday’s trading session with 2.18% gain, and closed at $45.90.
Intrexon Corporation (XON) declared that it has reached a partnership with an investment fund sponsored by Harvest Capital Strategies, LLC. The fund is believed to be the world’s first that is dedicated to the inventions and discoveries of a single company.
Intrexon has agreed to provide the fund a noteworthy number of investment proposals from across five sectors – Health, Energy, Food, Environment and Consumer – that are suitable for pursuit by a startup, counting several in 2015. With respect to such proposals, Intrexon will provide the fund with exclusive rights of first-look and first negotiation. Intrexon presently sees the potential to form up to ten new companies per year, each of which will have access to Intrexon’s proprietary technology platform through an Exclusive Channel Collaboration. Although the partnership with the fund will be complimentary to programs already underway at Intrexon, nothing in the arrangement will limit the Company’s ability to execute other collaborations and joint ventures.
Intrexon Corporation, a biotechnology company, operates in the synthetic biology field in the United States. The company, through a suite of proprietary and complementary technologies, designs, builds, and regulates gene programs, which are DNA sequences that comprise of key genetic components. Its technologies comprise UltraVector gene design and fabrication platform, and its associated library of modular DNA components; cell systems informatics; RheoSwitch inducible gene switch; AttSite Recombinases; protein engineering; mAbLogix; and laser-enabled analysis and processing. Intrexon Corporation has partnership agreements with ZIOPHARM Oncology, Inc.; Synthetic Biologics, Inc.; Oragenics, Inc.; Fibrocell Science, Inc.; Genopaver, LLC; AquaBounty Technologies, Inc.; S & I Ophthalmic, LLC; Biological & Popular Culture, Inc.; OvaXon, LLC; Intrexon Energy Partners, LLC; and Persea Bio, LLC; and planned partnershipand licensing agreement with Merck Serono S.A. The company was formerly known as Genomatix Ltd. and changed its name to Intrexon Corporation in 2005. Intrexon Corporation was founded in 1998 and is based in Germantown, Maryland.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
